AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing, 2020: France, Germany, Italy, Spain, UK - ResearchAndMarkets.com

January 27, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 27, 2020--

The “2020 Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: France, Germany, Italy, Spain, UK - Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies” report has been added to ResearchAndMarkets.com’s offering.

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

This new five-country study from the author contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Report Highlights

Rationale

Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

European Market Overview

Market Segmentation Analysis

Product/Technology Review

Competitive Assessments

Opportunities and Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/ptq4xn

View source version on businesswire.com:https://www.businesswire.com/news/home/20200127005351/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD: EUROPE

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/27/2020 08:20 AM/DISC: 01/27/2020 08:20 AM

http://www.businesswire.com/news/home/20200127005351/en